UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2016 UpToDate®

Management of widow spider bites

Authors
Richard S Vetter, MS
David L Swanson, MD
Julian White, AM, MB, BS, MD, FACTM
Section Editors
Stephen J Traub, MD
Daniel F Danzl, MD
Deputy Editor
James F Wiley, II, MD, MPH

INTRODUCTION

This topic will review the management of widow spiders (genus Latrodectus) bites. Clinical manifestations, diagnosis, and differential diagnosis of widow spider bites, recluse spider bites, and an overview of the approach to a suspected spider bite are discussed separately. (See "Clinical manifestations and diagnosis of widow spider bites" and "Bites of recluse spiders" and "Approach to the patient with a suspected spider bite: An overview".)

APPROACH

The approach to widow spider bites depends upon the severity of envenomation (see "Clinical manifestations and diagnosis of widow spider bites", section on 'Clinical manifestations'):

Mild envenomation – Mild widow spider envenomation consists of local skin irritation that may also be associated with local muscle pain and spasms adjacent to the bite.

Moderate envenomation – Generalized spasmodic muscle pain in the bitten extremity, sometimes involving the back, chest, or abdomen, and accompanied by local diaphoresis constitutes the common manifestations of moderate envenomation.

Severe envenomation – Severe envenomation causes pain that is severe and difficult to control or accompanied by systemic findings such as tachycardia and hypertension, nausea and vomiting, or headache.

             

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Nov 2016. | This topic last updated: Tue Aug 30 00:00:00 GMT+00:00 2016.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2016 UpToDate, Inc.
References
Top
  1. Clark RF, Wethern-Kestner S, Vance MV, Gerkin R. Clinical presentation and treatment of black widow spider envenomation: a review of 163 cases. Ann Emerg Med 1992; 21:782.
  2. Isbister GK, Fan HW. Spider bite. Lancet 2011; 378:2039.
  3. Monte AA, Bucher-Bartelson B, Heard KJ. A US perspective of symptomatic Latrodectus spp. envenomation and treatment: a National Poison Data System review. Ann Pharmacother 2011; 45:1491.
  4. Vetter RS, Swanson DL, Weinstein SA, White J. Do spiders vector bacteria during bites? The evidence indicates otherwise. Toxicon 2015; 93:171.
  5. Ellis RM, Sprivulis PC, Jelinek GA, et al. A double-blind, randomized trial of intravenous versus intramuscular antivenom for red-back spider envenoming. Emerg Med Australas 2005; 17:152.
  6. Isbister GK, Brown SG, Miller M, et al. A randomised controlled trial of intramuscular vs. intravenous antivenom for latrodectism--the RAVE study. QJM 2008; 101:557.
  7. Sutherland SK, Trinca JC. Survey of 2144 cases of red-back spider bites: Australia and New Zealand, 1963--1976. Med J Aust 1978; 2:620.
  8. White J. Envenoming and antivenom use in Australia. Toxicon 1998; 36:1483.
  9. Clark RF. The safety and efficacy of antivenin Latrodectus mactans. J Toxicol Clin Toxicol 2001; 39:125.
  10. Murphy CM, Hong JJ, Beuhler MC. Anaphylaxis with Latrodectus antivenin resulting in cardiac arrest. J Med Toxicol 2011; 7:317.
  11. Ramialiharisoa A, de Haro L, Jouglard J, Goyffon M. [Latrodectism in Madagascar]. Med Trop (Mars) 1994; 54:127.
  12. Gaisford K, Kautz DD. Black widow spider bite: a case study. Dimens Crit Care Nurs 2011; 30:79.
  13. Dart RC, Bogdan G, Heard K, et al. A randomized, double-blind, placebo-controlled trial of a highly purified equine F(ab)2 antibody black widow spider antivenom. Ann Emerg Med 2013; 61:458.
  14. http://www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/Shortages/default.htm (Accessed on April 03, 2013).
  15. Dzelalija B, Medic A. Latrodectus bites in northern Dalmatia, Croatia: clinical, laboratory, epidemiological, and therapeutical aspects. Croat Med J 2003; 44:135.
  16. Isbister GK, Graudins A, White J, Warrell D. Antivenom treatment in arachnidism. J Toxicol Clin Toxicol 2003; 41:291.
  17. Graudins A, Gunja N, Broady KW, Nicholson GM. Clinical and in vitro evidence for the efficacy of Australian red-back spider (Latrodectus hasselti) antivenom in the treatment of envenomation by a Cupboard spider (Steatoda grossa). Toxicon 2002; 40:767.
  18. Daly FF, Hill RE, Bogdan GM, Dart RC. Neutralization of Latrodectus mactans and L. hesperus venom by redback spider (L. hasseltii) antivenom. J Toxicol Clin Toxicol 2001; 39:119.
  19. Extension of expiration date for black widow spider antivenom packaged lot H019984 until January 3, 2015 and instructions for diluent use. US Food and Drug Administration. http://www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/ucm404162.htm (accessed July 14, 2015).
  20. Isbister GK, Gray MR. Latrodectism: a prospective cohort study of bites by formally identified redback spiders. Med J Aust 2003; 179:88.
  21. Isbister GK, Page CB, Buckley NA, et al. Randomized controlled trial of intravenous antivenom versus placebo for latrodectism: the second Redback Antivenom Evaluation (RAVE-II) study. Ann Emerg Med 2014; 64:620.
  22. Soh SY, Rutherford G. Evidence behind the WHO guidelines: hospital care for children: should s/c adrenaline, hydrocortisone or antihistamines be used as premedication for snake antivenom? J Trop Pediatr 2006; 52:155.
  23. Russell FE, Marcus P, Streng JA. Black widow spider envenomation during pregnancy. Report of a case. Toxicon 1979; 17:188.
  24. Sherman RP, Groll JM, Gonzalez DI, Aerts MA. Black widow spider (Latrodectus mactans) envenomation in a term pregnancy. Curr Surg 2000; 57:346.
  25. Handel CC, Izquierdo LA, Curet LB. Black widow spider (Latrodectus mactans) bite during pregnancy. West J Med 1994; 160:261.
  26. Wolfe MD, Myers O, Caravati EM, et al. Black widow spider envenomation in pregnancy. J Matern Fetal Neonatal Med 2011; 24:122.
  27. Isbister GK. Failure of intramuscular antivenom in Red-back spider envenoming. Emerg Med (Fremantle) 2002; 14:436.
  28. Isbister GK. Safety of i.v. administration of redback spider antivenom. Intern Med J 2007; 37:820.
  29. Brown SG, Isbister GK, Stokes B. Route of administration of redback spider bite antivenom: determining clinician beliefs to facilitate Bayesian analysis of a clinical trial. Emerg Med Australas 2007; 19:458.
  30. WIENER S. Red back spider bite in Australia: an analysis of 167 cases. Med J Aust 1961; 48(2):44.
  31. Jelinek GA, Banham ND, Dunjey SJ. Red-back spider-bites at Fremantle Hospital, 1982-1987. Med J Aust 1989; 150:693.
  32. Nordt SP, Clark RF, Lee A, et al. Examination of adverse events following black widow antivenom use in California. Clin Toxicol (Phila) 2012; 50:70.
  33. O'Malley GF, Dart RC, Kuffner EF. Successful treatment of latrodectism with antivenin after 90 hours. N Engl J Med 1999; 340:657.
  34. Suntorntham S, Roberts JR, Nilsen GJ. Dramatic clinical response to the delayed administration of black widow spider antivenin. Ann Emerg Med 1994; 24:1198.
  35. White J, Harbord M. Latrodectism as mimic. Med J Aust 1985; 142:75.
  36. Banham ND, Jelinek GA, Finch PM. Late treatment with antivenom in prolonged red-back spider envenomation. Med J Aust 1994; 161:379.
  37. de Silva HA, Pathmeswaran A, Ranasinha CD, et al. Low-dose adrenaline, promethazine, and hydrocortisone in the prevention of acute adverse reactions to antivenom following snakebite: a randomised, double-blind, placebo-controlled trial. PLoS Med 2011; 8:e1000435.
  38. Bush SP, Smith JC. Spider envenomation, widow. www.emedicine.com/emerg/topic546.htm (Accessed on September 30, 2008).
  39. White J. Snakebite & Spiderbite: Management Guidelines for South Australia. Dept. of Health, Government of South Australia, 2006. Accessible at: http://www.sahealth.sa.gov.au/wps/wcm/connect/public+content/sa+health+internet/health+information/health+information+for+the+clinician/snakebite+and+spider.
  40. CSL Antivenom Handbook. http://www.toxinology.com/generic_static_files/cslb_index.html (Accessed on October 14, 2008).